1
|
Yu YN, Ren YY, Shao ZL, Chen BL, Cui BY, Chao CY, Guo LJ, Guo S, Zhang MX, Wang SX, Zhu ML, Yin YL, Li P. Perillaldehyde improves diabetic cardiomyopathy by upregulating miR-133a-3p to regulate GSK-3β. Eur J Pharmacol 2023; 953:175836. [PMID: 37329971 DOI: 10.1016/j.ejphar.2023.175836] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Revised: 06/04/2023] [Accepted: 06/06/2023] [Indexed: 06/19/2023]
Abstract
Diabetic cardiomyopathy (DCM) is part of the most important causes of death from cardiovascular disease. Perillaldehyde (PAE), a major component of the herb perilla, has been shown to ameliorate doxorubicin-induced cardiotoxicity, but it is unclear whether PAE exerts beneficial effects on DCM. Exploring the potential molecular mechanisms of PAE for the treatment of DCM through network pharmacology and molecular docking. The SD rat type 1 diabetes model was established by a single intraperitoneal injection of streptozotocin (60 mg/kg), the cardiac function indexes of each group were detected by echocardiography; the morphological changes, apoptosis, protein expression of P-GSK-3β (S9), collagen I (Col-Ⅰ), collagen III (Col-Ⅲ) and alpha-smooth muscle actin (α-SMA), and miR-133a-3p expression levels were detected. An DCM model of H9c2 cells was established in vitro and transfected with Mimic and Inhibitor of miR-133a-3p. The results showed that PAE ameliorated cardiac dysfunction, reduced fasting glucose and cardiac weight index, and improved myocardial injury and apoptosis in DCM rats. It reduced high glucose-induced apoptosis, promoted migration and improved mitochondrial division injury in H9c2 cells. PAE decreased P-GSK-3β (S9), Col-Ⅰ, Col-Ⅲ and α-SMA protein expression and upregulated miR-133a-3p expression levels. After miR-133a-3p Inhibitor treatment, the expression of P-GSK-3β (S9) and α-SMA expression were significantly increased; after miR-133a-3p Mimic treatment, the expression of P-GSK-3β (S9) and α-SMA decreased significantly in H9c2 cells. It suggests that the mechanism of action of PAE to improve DCM may be related to the upregulation of miR-133a-3p and inhibition of P-GSK-3β expression.
Collapse
Affiliation(s)
- Ya-Nan Yu
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China
| | - Yuan-Yuan Ren
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China
| | - Zhen-Lei Shao
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China
| | - Bu-Lei Chen
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China
| | - Bao-Yue Cui
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China
| | | | - Li-Juan Guo
- Department of Oncology, Xinxiang Medical University First Affiliated Hospital, Xinxiang, 453119, China
| | - Shuang Guo
- Hubei Key Laboratory of Diabetes and Angiopathy, Hubei University of Science and Technology, Xianning, 437100, China
| | - Ming-Xiang Zhang
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China
| | - Shuang-Xi Wang
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China.
| | - Mo-Li Zhu
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China.
| | - Ya-Ling Yin
- School of Basic Medical Sciences, Sino-UK Joint Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Pathophysiology, Xinxiang Medical University, Xinxiang, 453003, China.
| | - Peng Li
- College of Pharmacy, Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Key Laboratory of Vascular Remodeling Intervention and Molecular Targeted Therapy Drug Development, Xinxiang Medical University, Xinxiang, 453003, China.
| |
Collapse
|
2
|
Yang Y, Xia Y, Zhang B, Li D, Yan J, Yang J, Sun J, Cao H, Wang Y, Zhang F. Effects of different n-6/n-3 polyunsaturated fatty acids ratios on lipid metabolism in patients with hyperlipidemia: a randomized controlled clinical trial. Front Nutr 2023; 10:1166702. [PMID: 37324747 PMCID: PMC10267450 DOI: 10.3389/fnut.2023.1166702] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Accepted: 05/11/2023] [Indexed: 06/17/2023] Open
Abstract
Background and aims Intake of n-3 polyunsaturated fatty acids (PUFA) is helpful for cardiometabolic health. It improves lipid metabolism, and increasing n-3 PUFA is often considered beneficial. However, the role of n-6/n-3 in the regulation of lipid metabolism has been much debated. Therefore, this study was performed on the effect of different proportions of n-6/n-3 diet on lipid metabolism, and quality of life in patients with hyperlipidemia, aiming to explore appropriate proportions of n-6/n-3 to provide the theoretical basis for the development and application of nutritional blended oil in the future. Methods These 75 participants were randomized and assigned into three groups, which received dietary oil with high n-6/n-3 PUFA ratios (HP group: n-6/n-3 = 7.5/1), dietary oil with middle n-6/n-3 PUFA ratios (MP group: n-6/n-3 = 2.5/1) or low n-6/n-3 PUFA ratios (LP group: n-6/n-3 = 1/2.5). All patients received dietary guidance and health education were monitored for hyperlipidemia. Anthropometric, lipid and blood glucose parameters and quality of life were assessed at baseline and 60 days after intervention. Result After 60 days, high-density lipoprotein cholesterol (HDL-c) level was increased (p = 0.029) and Total cholesterol (TC) level was decreased (p = 0.003) in the MP group. In the LP group, TC level was decreased (p = 0.001), TG level was decreased (p = 0.001), but HDL-c level was not significantly increased. At the end of intervention, quality of life' score was improved in both MP and LP groups (p = 0.037). Conclusion Decreasing the intake of edible oil n-6/n-3 ratio can improve blood lipids and quality of life. This is significant for the prevention of cardiovascular disease (CVD). It is also essential to note that an excessive reduction of the n-6/n-3 ratio does not further improve the blood lipid metabolism. In addition, the application of perilla oil in nutritional blended oil has particular significance. Clinical trial registration https://www.chictr.org.cn/indexEN.html, identifier ChiCTR-2300068198.
Collapse
Affiliation(s)
- Yiwei Yang
- Wuxi School of Medicine, Jiangnan University, Wuxi, China
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
| | - Yanping Xia
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| | - Baixi Zhang
- School of Food Science and Technology, Jiangnan University, Wuxi, China
| | - Dan Li
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| | - Jiai Yan
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| | - Ju Yang
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| | - Jing Sun
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| | - Hong Cao
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| | - Yingyu Wang
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| | - Feng Zhang
- Wuxi School of Medicine, Jiangnan University, Wuxi, China
- Department of Nutrition, Affiliated Hospital of Jiangnan University, Wuxi, China
- Clinical Evaluation Center for Functional Food, Affiliated Hospital of Jiangnan University, Wuxi, China
- Yixing Institute of Food and Biotechnology Co., Ltd., Yixing, China
| |
Collapse
|
3
|
Xu J, Zhang J, Lin H, Zhang J, Zhou R, Wu X, Niu Y, Zhang J. Preparation of oral nanoparticles of
Perillae Fructus
oil and prevention application of cold stress in mice. Food Sci Nutr 2022; 11:1728-1735. [PMID: 37051352 PMCID: PMC10084961 DOI: 10.1002/fsn3.3202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 12/03/2022] [Accepted: 12/13/2022] [Indexed: 12/24/2022] Open
Abstract
Perillae Fructus oil has an important function in relieving cold stress. However, its application in this aspect has still been restricted because of instability and low bioavailability. In this study, Perillae Fructus oil was extracted through Soxhlet extraction, analyzed through gas chromatography-mass spectrometry (GC-MS), and nanopackaged into a yeast shell for the preparation of nanoparticles for oral administration. The characteristics of the nanoparticles were investigated using a Malvern zeta-size nanoinstrument, scanning electron microscopy (SEM), and high-performance liquid chromatography (HPLC). Then, the roles of orally administered nanoparticles in relieving cold stress were evaluated by investigating blood physiological and biochemical indexes in mice. The results showed that the oil yield from Perillae Fructus and shell yield from yeast cells were ~48.37% and ~16.87%, respectively. Approximately 89.21% of the added oil was packaged into the yeast shell to form nanoparticles with an average diameter of 316.74 nm and a surface charge of +2.9 mV. The nanoparticles were stable in simulated gastric acid and could be effectively released in simulated intestinal fluid with an efficiency of ~91.34%. After oral administration of nanoparticles, the mouse blood indexes of white blood cells (WBCs), superoxide dismutase (SOD) activity, and malonaldehyde (MDA) content were recovered compared to those in model mice, with a more remarkable effect than oral administration of free Perillae Fructus oil. Overall, the stability and bioavailability were improved by packaging Perillae Fructus oil into a yeast shell. These nanoparticles are a new agent for the prevention of cold stress.
Collapse
Affiliation(s)
- Junfei Xu
- College of Biological and Food Engineering Huaihua University Huaihua China
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province Huaihua China
- "Double First‐Class" Applied Characteristic Discipline of Bioengineering in Hunan High Educational Institution Huaihua China
| | - Jianxi Zhang
- College of Biological and Food Engineering Huaihua University Huaihua China
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province Huaihua China
- "Double First‐Class" Applied Characteristic Discipline of Bioengineering in Hunan High Educational Institution Huaihua China
| | - Huiying Lin
- College of Biological and Food Engineering Huaihua University Huaihua China
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province Huaihua China
- "Double First‐Class" Applied Characteristic Discipline of Bioengineering in Hunan High Educational Institution Huaihua China
| | - Jiayu Zhang
- College of Biological and Food Engineering Huaihua University Huaihua China
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province Huaihua China
- "Double First‐Class" Applied Characteristic Discipline of Bioengineering in Hunan High Educational Institution Huaihua China
| | - Rong Zhou
- College of Biological and Food Engineering Huaihua University Huaihua China
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province Huaihua China
- "Double First‐Class" Applied Characteristic Discipline of Bioengineering in Hunan High Educational Institution Huaihua China
| | - Xianjin Wu
- College of Biological and Food Engineering Huaihua University Huaihua China
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province Huaihua China
- "Double First‐Class" Applied Characteristic Discipline of Bioengineering in Hunan High Educational Institution Huaihua China
| | - Youya Niu
- School of Basic Medical Sciences Hunan University of Medicine Huaihua China
| | - Juzuo Zhang
- College of Biological and Food Engineering Huaihua University Huaihua China
- Key Laboratory of Research and Utilization of Ethnomedicinal Plant Resources of Hunan Province Huaihua China
- "Double First‐Class" Applied Characteristic Discipline of Bioengineering in Hunan High Educational Institution Huaihua China
| |
Collapse
|